Genitourinary Syndrome of Menopause
Genitourinary Syndrome of Menopause
This course includes
The instructors
Overview
This course will review the hormonally mediated changes that cause the genitourinary syndrome of menopause as well as a treatment approach. Genitourinary Syndrome of Menopause (GSM) encompasses a range of symptoms and signs linked to reduced estrogen and testosterone levels affecting the vulva, vagina, urethra, and bladder. Clinical manifestations of GSM include vaginal dryness, irritation, burning sensations, dyspareunia (painful intercourse), urinary urgency, recurrent urinary tract infections, and dysuria (painful urination). The impact of GSM on quality of life is profound, as it can significantly affect physical comfort, sexual well-being, and overall lifestyle.
Dr. Michelle Jacobson delves into the essential elements and critical questions to address during both subjective and physical assessments of patients experiencing menopause or are post-menopause. She emphasizes the importance of a comprehensive evaluation to thoroughly understand the patient’s condition. A crucial aspect of this process is recognizing that GSM is a clinical condition characterized by a range of symptoms resulting from hormonal changes. The primary objective in managing GSM is to provide effective symptom relief, enhancing the patient’s overall quality of life. By addressing these key components and asking insightful questions, practitioners can tailor their treatment strategies to better meet the specific needs of their patients, ultimately aiming for improved outcomes and well-being.
In this course, we explore a range of evidence-based treatment modalities for GSM guided by the latest clinical practice guidelines from the North American Menopause Society and the Journal of Obstetrics and Gynecology of Canada. This includes the use of vaginal lubricants and moisturizers, various hormonal therapies, and the crucial role that pelvic physiotherapy plays in managing this condition. We delve into the most current research and recommendations to enhance your understanding and application of these treatments. By integrating the latest evidence and guidelines, you will gain a thorough grasp of the most effective strategies for alleviating symptoms and improving patient outcomes in the context of GSM.
Learning Objectives
In this online course, you will:
- Understand the pathophysiology behind the development of GSM
- Learn how to assess and screen patients for signs/symptoms of GSM
- Develop an approach to different treatment modalities for GSM including both prescription and non prescription options
- Appreciate the challenges of managing GSM for special populations (eg breast cancer survivors)
Audience
This course is tailored for pelvic health physiotherapists who offer specialized care to women navigating menopause or postmenopause, including those experiencing genitourinary syndrome of menopause. It is also perfect for practitioners seeking to deepen their knowledge of the broad spectrum of treatment options—both medical and hormonal—available for managing genitourinary syndrome of menopause.
The instructors
Pelvic Health Solutions (PHS) is an evidence-based teaching company that aims to educate and empower physiotherapists, healthcare professionals, and everyday people about pelvic health.
PHS was founded in 2010 out of the need to develop pelvic health resources in Ontario at a time when it was an under-serviced health concern. PHS provides continuing education courses, mentoring, and clinical resources for a variety of practitioners with the goal of equipping them to deliver evidence-based, biopsychosocial assessment and treatment of pelvic health problems in our province and abroad.
Our company also exists as a way to connect people experiencing pelvic health concerns to pelvic health physiotherapists in their area. PHS has ultimately blossomed into a community of curious people who are committed to providing hope and healing to those who suffer from pelvic health issues.
MD
Dr. Michelle Jacobson is a menopause specialist at Women’s College and Mount Sinai Hospitals in Toronto where she directs the familial ovarian cancer clinic. She did her residency at McMaster university and fellowship in Menopause at the University of Toronto, followed by a Masters of Health Science in translational research. She is the creator and director of the SOGC’s community of practice in Hereditary Breast and Ovarian Cancer and the primary author of the guidelines on the Gynaecologic Management of Hereditary Breast and Ovarian Cancer and Breast Cancer and Menopause.
Material included in this course
-
Welcome and Resources
-
Welcome!
-
Slides (2 per page)
-
Slides (6 per page)
-
Genitourinary Syndrome of Menopause
-
Genitourinary Syndrome of Menopause Signs and Symptoms
-
Treatment Options for Genitourinary Syndrome of Menopause
-
Hormone Therapies
-
Breast Cancer Patients- Special Considerations
-
Q&A
-
Quiz
-
What's Next?
-
Feedback